SEC Form D · filed December 26, 2019
Tarveda Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Guido J. Magni · Watertown, MADirectorNilesh J. Kumar · Watertown, MADirectorDennis J. Ausiello · Watertown, MADirectorMichael J. Metzger · Watertown, MADirectorAymeric J. Sallin · Watertown, MADirectorRobert J. Langer · Watertown, MADirectorOmid J. Farokhzad · Watertown, MADirectorAndrew J. Fromkin · Watertown, MAExec · DirectorAndy M. Wheeler · St. Louis, MODirectorNatalie B. Dinicola · St. Louis, MODirectorMichael B. Wainscott · St. Louis, MODirectorChris C. Wilkins · St. Louis, MODirectorMatthew B. Crisp · St. Louis, MODirectorKenneth T. Wong · NEW YORK, NYDirectorRichard T. O'Toole · NEW YORK, NYDirectorWilliam B. Janes · Chicago, ILDirectorWilliam B. Janes · Chicago, ILDirectorPeter Wirth · Cambridge, MADirectorRobert J. Langer · Watertown, MADirectorOmid J. Farokhzad · Watertown, MADirectorAndrew J. Fromkin · Watertown, MAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗